| 1 |
<p align=center><img src="p/pliva_president.gif" width="269" height="16"></p> |
<p align=center><img src="p/pliva_president.gif" width="269" height="16"></p> |
| 2 |
<p align=left><img src="p/president.jpg" width="105" height="125" align="left" vspace="5" hspace="10" border="1"></p> |
<p align=left><img src="p/president.jpg" width="105" height="125" align="left" vspace="5" hspace="10" border="1"></p> |
| 3 |
<p align=left> |
<p align=left> |
| 4 |
<b>Welcome to PLIVA!</b></p> |
<b>Welcome to PLIVA!</b></p> |
| 5 |
<p align=left> |
<p align=left> |
| 6 |
I would like to take this opportunity to welcome and introduce you to PLIVA, |
I would like to take this opportunity to welcome you to PLIVA, the leading pharmaceutical company in Central and Eastern Europe. Since its 1996 listing on the London and Zagreb Stock Exchanges, PLIVA has made notable advancements in internationalising its business and implementing a global and innovative strategy. PLIVA is a rather unique company with investments in both research and development. With over 400 patents in its possession, PLIVA has proven the high calibre of its R&D capabilities, most notably through the discovery of its blockbuster - azithromycin. This macrolide antibiotic, globally known as Zithromax (under license to Pfizer) or Sumamed (PLIVA’s brand), is the top selling antibiotic in its class. Building on its long history of R&D expertise and innovation, PLIVA has developed strong NCE and Generics programmes, an invaluable investment for PLIVA's sustained growth. Our business model and processes are the optimal combination of these R&D activities with international expansion through which PLIVA will continue to grow and enhance shareholder value. |
| 7 |
the leading pharmaceutical company in Central and Eastern Europe. Since its 1996 |
</p> |
| 8 |
listing on the London and Zagreb Stock Exchanges, PLIVA has made notable |
<p align=left>I am very proud of PLIVA's accomplishments, but most of all, I take pride in our people, who made these advancements possible. The innovation and commitment of scientists and technicians in PLIVA's Research Institute has led to the discovery of azithromycin as well as the start of clinical trials for a number of new drugs and the development of over 40 new generic drugs. |
| 9 |
advancements in internationalising its business and implementing a global and |
</p> |
| 10 |
innovative strategy. PLIVA represents a rather unique company with investments |
<p align=left>The commitment to quality demonstrated by the PLIVA team, from the top management through to production line staff, has gained the trust of our customers in our products. PLIVA's marketing and sales teams have focused their attention on customer needs - not only on satisfying their needs, but also exceeding their expectations. These values and this approach are an integral part of PLIVA's operations worldwide. |
| 11 |
in both research and development. With over 400 patents in possession, PLIVA has |
</p> |
| 12 |
proven the high calibre of its R&D capabilities, most notably through its |
<p align=left>PLIVA |
| 13 |
discovery of the blockbuster azithromycin. This macrolide antibiotic, globally |
is people dedicated to helping other people around the world live healthier |
| 14 |
known as Zithromax (under license by Pfizer) or Sumamed (PLIVA brand), represents |
and longer lives by providing innovative, high quality medicines and solutions.</p> |
| 15 |
the top selling antibiotic of its class. Building on a long history of R&D |
<p align=left> |
| 16 |
expertise and innovation, PLIVA has developed a strong NCE and Generics |
Zeljko Covic </p> |
|
programmes, |
|
|
an invaluable investment for PLIVA's sustainable growth. Our business model and |
|
|
processes represent an optimal combination of these R&D activities with |
|
|
international expansion, through which PLIVA will continue to grow and create |
|
|
shareholder value. </p> |
|
|
<p align=left>I am very proud of PLIVA's accomplishments, but most of all, I take |
|
|
pride in our people who made these advancements possible. The innovation and |
|
|
commitment of scientists and technicians of PLIVA's Research Institute has led to |
|
|
the discovery of azithromycin as well as the start of clinical trials for a |
|
|
number of new drugs and the development of over 40 new generic drugs. |
|
|
</p> |
|
|
<p align=left> The commitment to quality demonstrated by the PLIVA team, |
|
|
including top management through production staff line staff, has gained our |
|
|
customers trust in our products. PLIVA's marketing and sales teams have focused |
|
|
their attention on customer needs - not only on satisfying their needs, but also |
|
|
exceeding their expectations. These values and approach are an integral part of |
|
|
PLIVA's operations worldwide.</p> |
|
|
<p align=left>PLIVA |
|
|
is people dedicated to helping other people around the world live healthier |
|
|
and longer lives by providing innovative, high quality medicines and solutions.</p> |
|
|
<p align=left> |
|
|
Zeljko Covic </p> |
|
|
</body> |
|
|
</html> |
|
Parent Directory
| 
Revision Log
| 
Patch